image
Healthcare - Biotechnology - NASDAQ - US
$ 0.6211
-6.52 %
$ 74.3 M
Market Cap
-1.08
P/E
BALANCE SHEET
31.7 M ASSETS
123.16%
24.2 M LIABILITIES
34.65%
7.43 M EQUITY
295.09%
BALANCE SHEET DECOMPOSITION
Balance Sheet Unicycive Therapeutics, Inc.
image
Current Assets 30.9 M
Cash & Short-Term Investments 26.1 M
Receivables 0
Other Current Assets 4.81 M
Non-Current Assets 720 K
Long-Term Investments 0
PP&E 720 K
Other Non-Current Assets 0
82.55 %15.18 %Total Assets$31.7m
Current Liabilities 24.1 M
Accounts Payable 966 K
Short-Term Debt 92 K
Other Current Liabilities 23.1 M
Non-Current Liabilities 117 K
Long-Term Debt 0
Other Non-Current Liabilities 117 K
3.99 %95.15 %Total Liabilities$24.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 26.1 9.7 0.5 16.6 0 15 K 25 K
Short Term Investments 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 0.9 3.7 2.2 1.8 0.2 4 K 4 K
Total Current Assets 30.9 13.4 2.6 18.4 0.2 19 K 29 K
PP&E 0.7 0.8 0.2 0.3 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0 0 (0.2) (0.3) 0.2 0 0
Other Assets 0 0 0 0 (0.2) 0 0
Total Assets 31.7 14.2 2.8 18.7 0.2 19 K 29 K
LIABILITIES
Accounts Payable 1.0 0.8 0.8 0.7 0.2 0.3 60 K
Short Term Debt 92 K 0.3 0.3 0.3 2.5 0.5 1.0
Other Current Liabilities 23.1 16.4 2.1 1.1 0.2 0.1 0.1
Total Current Liabilities 24.1 17.5 3.3 2.1 2.9 0.9 1.2
Long Term Debt 0 0.5 0 0.2 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0
Total Liabilities 24.2 18.0 3.3 2.3 2.9 0.9 1.2
EQUITY
Common Stock 0.1 35 K 15 K 15 K 9 K 8 K 34 K
Retained Earnings (101.3) (64.5) (34.0) (15.9) (5.9) (3.7) (1.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0
Total Equity 7.4 (3.8) (0.5) 16.5 (2.7) (0.9) (1.2)
Total Liabilities and Equity 31.7 14.2 2.8 18.7 0.2 19 K 29 K
SHARES OUTSTANDING
Common Shares Outstanding 669.9 24.5 15.1 15.0 15.2 8.4 7.9